Inhibition of CSF1R signaling may provide an intervention approach or therapeutic due to the inhibition of the process of amyloid deposition formation at the very earliest stages of Alzheimer's disease [44]. Here, CSF1R is linked to early-onset autosomal dominant Alzheimer disease.